China National Accord Medicines Corporation Ltd. (SHE: 000028)

Market Cap	15.77B
Revenue (ttm)	75.36B
Net Income (ttm)	1.48B
Shares Out	556.57M
EPS (ttm)	2.64
PE Ratio	11.54
Forward PE	12.64
Dividend	0.68 (2.19%)
Ex-Dividend Date	Jun 25, 2024

Volume	5,413,388
Open	30.39
Previous Close	31.10
Day's Range	30.39 - 31.08
52-Week Range	23.84 - 42.13
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About China National Accord Medicines Corporation

China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. it offers drugs, medical equipment, cargo transportation, warehousing, loading and unloading, glass instruments, cosmetics, sales of daily necessities, other business services, other professional consulting, and self-management services; agent services; import and export of various commodities and technologies; and house leasing services. The company is also involved in the import and export of proprie...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 39,449
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000028

Financial Performance

In 2023, China National Accord Medicines Corporation's revenue was 75.48 billion, an increase of 2.77% compared to the previous year's 73.44 billion. Earnings were 1.60 billion, an increase of 7.57%.